{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-22-002838","form_type":"8-K","ticker":"ODYY","cik":"0001626644","company_name":"Odyssey Health, Inc.","filed_at":"2022-04-20T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.540927+00:00","generated_at":"2026-06-26T06:12:03.267484+00:00","sec_items":["8.01","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Odyssey Health adds Vice Admiral (r) Timothy Szymanski to Military Advisory Board","bullets":["Vice Admiral (r) Szymanski served 36 years as Navy SEAL, most recently Deputy Commander USSOCOM.","He established cognitive baseline policy for Special Operations and created brain health initiatives.","Odyssey's concussion drug candidate PRV-002 is currently in Phase 1 clinical trial.","Up to 3.8 million concussions occur annually in the U.S., with 30-50% unreported."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-22-002838","json":"https://secwatch.observer/filing/0001683168-22-002838.json","markdown":"https://secwatch.observer/filing/0001683168-22-002838.md","text":"https://secwatch.observer/filing/0001683168-22-002838.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1626644/000168316822002838/0001683168-22-002838-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1626644/000168316822002838/ody_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T06:12:03.267484+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}